CD8A and neoplasm: In addition, stage I and III ADCs showed closer proximity of CD3 + CD8negFOXP3 + regulatory T-cells to cytotoxic CD3 + CD8 + T-cells than did stage II tumors, suggesting changes according to the stage of the tumor.